New England Journal of Medicine · 1979 · 326 citations · 22 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyImmunology Of Infectious DiseasesImmunopathologyB Cell ActivationCellular Immunity In InfectionHumoral ImmunityLymphocyte ActivationT Cell ActivationT Cell BiologyAdaptive Immune Responses To Viral InfectionB Cell Responses To InfectionCausative PathogensCell ActivationImmunoglobulin ProductionInfectious MononucleosisSuppressor Cell Biology
Infectious mononucleosis is caused by Epstein‑Barr virus, which preferentially infects B lymphocytes and triggers their immunoglobulin production. During infection, suppressor T cells become activated and suppress further B‑cell activation. EBV induces early hypergammaglobulinemia, but activated suppressor T cells later reduce circulating immunoglobulin‑secreting cells, thereby limiting B‑cell proliferation and providing host defense. N Engl J Med 301:1133–1137, 1979.
Infectious mononucleosis is caused by the Epstein-Barr virus (EBV), an unusual human pathogen because it preferentially infects B lymphocytes and consequently activates them to produce immunoglobulins. When cultures of lymphocytes from patients with infectious mononucleosis were stimulated with polyclonal activators, unseparated cells failed to produce immunoglobulins, whereas purified B cells responded normally. Cocultures demonstrated profound suppressor T-cell activity in blood from patients with infectious mononucleosis. Early in this disease, circulating immunoglobulin-secreting cells were elevated, but during the second week their number was strikingly depressed. These data indicate that during infectious mononucleosis, EBV causes polyclonal activation of B cells, reflected by hypergammaglobulinemia and increased circulating immunoglobulin-secreting cells. Next, suppressor T cells become activated and inhibit further B-cell activation. Thus, activation of suppressor T cells in infectious mononucleosis provides a unique additional mechanism of host defense because these T cells inhibit the activation and proliferation of an important target of the causative virus. (N Engl J Med 301:1133–1137, 1979)
22
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro
Anders Rosén, P Gergely, Mikael Jondal et al. · Nature · 1977 · 381 citations